Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, with reference to his Department's press release of 12 December 2024 entitled £100 million public-private health research boost from which budget is the public sector funding coming; and what proportion is public investment.
The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) Investment Programme is enabled by circa £400m of funding from scheme members over 5 years.
Approximately 75% of total Investment Programme funding will boost commercial clinical trials across the UK, including through the new Commercial Research Delivery Centres (CRDCs).
The CRCDs are a public-private investment which include funding from the VPAG Investment Programme and £71m additional funding in England from the National Institute for Health and Care Research (NIHR).